Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Atorvastatin with Tipranavir/Ritonavir and Antacid Effect
NCT02245269Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2003
- Primary completion
- Oct 2003
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the plasma drug concentration-time curve from time zero to infinity, Maximum plasma concentration and 2 more. Started Jul 2003; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02245269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245269.